NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its second-quarter revenues increased 4 percent year over year, beating Wall Street estimates on the top and bottom line.

The Waltham, Mass.-based firm brought in total revenues of $543.3 million for the three months ended June 30, compared to $521.8 million for the second quarter of 2012. Analysts, on average, had expected revenues of $533 million.

Its organic revenue growth for the quarter was 3 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.